Cleared Traditional

K833796 - CHEM KIT PHENOBARBITAL

K833796 is an FDA 510(k) clearance for CHEM KIT PHENOBARBITAL, manufactured by Abbott Laboratories. The device is a Class 2 Toxicology device with product code DLZ cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K833796 · Abbott Laboratories · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
90d
Days
Class 2
Risk

K833796 is an FDA 510(k) clearance for the CHEM KIT PHENOBARBITAL. Classified as Enzyme Immunoassay, Phenobarbital (product code DLZ), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on January 30, 1984 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3660 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K833796

510(k) Number K833796 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 1983
Decision Date January 30, 1984
Days to Decision 90 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 87d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DLZ Device Classification - Class 2, Special Controls

Product Code DLZ Enzyme Immunoassay, Phenobarbital
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DLZ Enzyme Immunoassay, Phenobarbital

All 33
Devices cleared under the same product code (DLZ) and FDA review panel - the closest regulatory comparables to K833796.
SERA ARIS PHENO REAG STRIP, TEST MOD CAL & CLT
K852946 · Miles Laboratories, Inc. · Sep 1985
ENDAB PHENOBARBITAL
K852995 · Immunotech Corp. · Aug 1985
VENTREZYME PHENOBARBITAL KIT IMMUNO
K842264 · Ventrex Laboratories, Inc. · Aug 1984
EMIT QST PHENOBARBITAL ASSAY
K834216 · Syva Co. · Jan 1984
A-GENT PHENOBARBITAL
K832457 · Abbott Laboratories · Sep 1983
PHENOBARTIAL ASSAY USE ON COBAS-BIO
K832097 · Syva Co. · Aug 1983